Filip Dubovsky, President, R&D at NOVAVAX INC (NVAX), sold 94,624 shares at $13.90 ($1.3M) on 2024-05-14, disclosed to the SEC on 2024-05-15.
Open-market sale of $1.3M NVAX by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.90 | 47,312 | $658K | 50.0% |
| 2 | $13.90 | 47,312 | $658K | 50.0% |
| Total | $13.90 avg | 94,624 | $1.3M | 100% |